1. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, еt al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013;72(5):683-693. doi: 10.1136/annrheumdis-2012-201483. IF2 = 12,384; IF5 = 9,999
2. Miettunen P, Pistorio A, Palmisani E, Ravelli A, Silverman E, Oliveira S, Alessio M, Cuttica R, Mihaylova D, Espada G, Pasic S, Insalaco A, Ozen S, Porras O, Sztajnbok F, Lazarevic D, Martini A, Ruperto N. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study. Ann Rheum Dis 2013; 72(9):1503-1509. doi: 10.1136/annrheumdis-2012-201937. IF2 = 12,384; IF5 = 9,999
3. Milenković J, Vojinović J, Debeljak M, Toplak N, Lazarević D, Avčin T, et al. Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation. Pediatr Rheumatol 2016; 14(1):39. doi: 10.1186/s12969-016-0097-1. IF2 = 2,543; IF5 = 2,668
4. Varnier GC, Rosina S, Ferrari C, Pistorio A, Consolaro A....., Lazarevic D et al. Development and testing of a hybrid measure of muscle strengt in juvenile dermatomyositis for use in routine care. Аrthritis Care Res (Hoboken) 2018; 70(9):1312-1319. doi: 10.1002/acr.23491. IF2 = 4,149; IF5 = 4,905
5. Lazarević D, Nikolić I, Ratković-Janković M, Vojinović J. Outcome of juvenile idiopathic arthritis (JIA) associated uveitis in two diseases subtypes. Arch Rheumatol 2017; 32(1):26-31. doi:10.5606/ArchRheumatol.2017.6060. IF2 = 0,208; IF5 = 0,233
6. Susic G, Vojinovic J, Vijatov Djuric G, Stevanovic D, Lazarevic D, Djurovic N et al. The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int 2018; 38 (Suppl 1):S347–S354. doi: 10.1007/s00296-018-3972-x. IF2 = 1,952; IF5 = 1,803
7. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Sušić G, Lazarević D, Milošević V, Cvetković M, Pavlović D. Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis. Clin Rheumatol 2019; 38(1):117-124. IF2=2. 394 IF5 =2.380 (M23ili M22)
8. Rosina S, Consolaro A, Dijkhuizen P, Pistorio A, Varnier GC, Bovis F....Lazarevic D. et al. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. Rheumatology 2019;58(7):1196-1205. IF2= 5.606 IF50=5.35 (M21)
9. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Lazarević D. et al. The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis Rheumatol Int 2019;39(3):551-559. IF2= 2,2 IF5= 2.056 (M23).
10. Stamenkovic HM, Lazarevic D, Stankovic T, Vojinovic J, Lekic B, Marinkovic A, Bosic M. Linear IgA dermatosis of the childhood-Report of an amoxicillin-induced case. Dermatol Ther 2019; e13173. https://doi.org/10.1111/dth.13173 IF2 = 3.615 (M21)
11.Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Tererii MT, Sakamoto AP...... Lazarevic D. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com. Arthritis Care Res (Hoboken). 2021 Mar 30. doi: 10.1002/acr.24609. Online ahead of print. IF2 =4.794 IF5=5.308
1. Vojinović J, Lazarević D, Pejčić Lj, Ratković-Janković M, Nikolić I, Jakovljević M. Аdvances in ultrasound application in juvenile idiopathic arthritis. Paediatr Cro 2017;61 (Supl 1):1-5
2. Radovic J, Lazarevic D, Nikolic I, Vojinovic J. Effect of Alfacalcidol on Oxidative Stress and Disease Activity in JIA Patients. Ann Paediatr Rheum 2012; 1(2): 126-132.
3. Vojinović J., Sušić G., Lazarević D. Diferencijalna dijagnoza artritisa dečijeg uzrasta. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2010; Vol 40 Suppl 2: 63-67.
4. Sušić G, Gordana Vijatov-Đurić, Lazarević D. Dijagnoza i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2016; Vol 46 Suppl 1: 131-134.
5. Lazarević D. Poliartikularni artritis - Prevencija hroničnih oštećenja zglobova. Predavanje po pozivu štampano u celosti. Prev Ped 2017; Vol 3 (1-2): 21-24.
6. Lazarević D, Milenković J, Vojinović J. Predavanje po pozivu štampano u celosti. Autoinflamatorne bolesti. Balneoclimactologia 2018; Vol 42 (1): 105-117.
7. Lazarević D, Ratković-Janković M, Jakovljević M, Vojinović J. Dugotrajna efikasnost i bezbednost primene adalimumaba u lečenju juvenilnog idiopatskog artritisa (JIA) sa uveitisom Long term efficacy and safety of adalimumab in Juvenile Idiopathic Arthritis (JIA) associated uveitis. Acta Medica Medianae 2021 doi:10.5633/amm.2021.0304.